首页> 外文期刊>International Journal of Pharmaceutics >Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
【24h】

Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.

机译:通过双层包衣制备的5-单硝酸异山梨酯(5-ISMN)缓释微丸,可减少5-ISMN迁移和升华。

获取原文
获取原文并翻译 | 示例
       

摘要

The major aim of this study was to prepare isosorbide-5-mononitrate (5-ISMN) sustained-release pellets and evaluate their stability. The pellets were prepared by extrusion/spheronization, and then the core pellets were coated with ethylcellulose (EC 10cp) and Eudragit((R))NE30D. Here, EC was used as the subcoating agent while Eudragit((R))NE30D acted as the outer-coating agent. 5-ISMN sustained-release pellets as a novel drug delivery system contained the immediate-release portion in the outer-coating layer. Unexpectedly, 5-ISMN was found to migrate from the interior of the pellets to the surface forming needle crystals and exhibited the phenomenon of sublimation, which resulted in a tremendous increase in the release rate. Our research showed that the migration and sublimation of the active ingredient was related to the temperature and humidity. Polyvinylpyrrolidone (PVP K30) can affect the precipitation of 5-ISMN by forming a charge transfer complex between the drug and PVP, while hydroxypropyl methyl cellulose (HPMC E5) had no effect, and confirmed the correctness of this view through photographs and IR spectra. In the investigation of the stability, the results showed that there was no sublimation and migration while the pellets stored at 25 degrees C/60%RH (ambient conditions) and 40 degrees C/75% RH (stress conditions) during a 6-month period.
机译:这项研究的主要目的是制备5-单硝酸异山梨酯(5-ISMN)缓释微丸并评估其稳定性。通过挤出/滚圆制备粒料,然后将芯粒用乙基纤维素(EC 10cp)和EudragitNE30D包衣。此处,EC用作底涂层剂,而EudragitNE30D用作外涂层剂。 5-ISMN缓释微丸作为新型药物输送系统,在外涂层中包含速释部分。出乎意料的是,发现5-ISMN从丸粒内部迁移到表面形成针状晶体并表现出升华现象,这导致释放速率的极大提高。我们的研究表明,活性成分的迁移和升华与温度和湿度有关。聚乙烯吡咯烷酮(PVP K30)可以通过在药物和PVP之间形成电荷转移复合物来影响5-ISMN的沉淀,而羟丙基甲基纤维素(HPMC E5)没有作用,并通过照片和红外光谱证实了该观点的正确性。在稳定性研究中,结果表明,在6个月内,颗粒在25°C / 60%RH(环境条件)和40°C / 75%RH(应力条件)下存储时,没有升华和迁移。期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号